Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pediatric Patients With Solid Tumors”

158 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 158 results

Early research (Phase 1)Study completedNCT00186953
What this trial is testing

Determination of a Safe Dose of Optison in Pediatric Patients With Solid Tumors

Who this might be right for
Abdominal NeoplasmsPelvic Neoplasms
St. Jude Children's Research Hospital 14
Testing effectiveness (Phase 2)Active Not RecruitingNCT04320888
What this trial is testing

Selpercatinib for the Treatment of Advanced Solid Tumors, Lymphomas, or Histiocytic Disorders With Activating RET Gene Alterations, a Pediatric MATCH Treatment Trial

Who this might be right for
Hematopoietic and Lymphatic System NeoplasmRecurrent EpendymomaRecurrent Ewing Sarcoma+35 more
National Cancer Institute (NCI) 1
Early research (Phase 1)Ended earlyNCT00101205
What this trial is testing

Oxaliplatin, Ifosfamide and Etoposide in Treating Young Patients With Recurrent or Refractory Solid Tumors or Lymphoma

Who this might be right for
Angioimmunoblastic T-cell LymphomaB-cell Childhood Acute Lymphoblastic LeukemiaB-cell Chronic Lymphocytic Leukemia+24 more
National Cancer Institute (NCI) 40
Post-approval studies (Phase 4)Study completedNCT02095951
What this trial is testing

Preemptive Ethanol Lock Therapy in Pediatric Bloodstream Infection

Who this might be right for
LeukemiaLymphomaBlood Disorders+1 more
Children's Hospital of Michigan 30
Testing effectiveness (Phase 2)Ended earlyNCT03458728
What this trial is testing

Safety, Tolerability, Efficacy and Pharmacokinetics of Copanlisib in Pediatric Patients

Who this might be right for
Relapsed or Refractory Solid Tumors or Lymphoma in ChildrenNeuroblastomaOsteosarcoma+2 more
Bayer 31
Not applicableLooking for participantsNCT06730204
What this trial is testing

Standardized Nutritional Management of Pediatric Patients With Solid Tumors

Who this might be right for
Tumor, SolidChildrenNutritional Intervention
Children's Hospital of Fudan University 400
Testing effectiveness (Phase 2)Ended earlyNCT01295697
What this trial is testing

Study of EZN-2208 Pediatric Patients With Solid Tumors

Who this might be right for
Solid Tumors
Enzon Pharmaceuticals, Inc. 32
Testing effectiveness (Phase 2)Study completedNCT03526250
What this trial is testing

Palbociclib in Treating Patients With Relapsed or Refractory Rb Positive Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Activating Alterations in Cell Cycle Genes (A Pediatric MATCH Treatment Trial)

Who this might be right for
Advanced Malignant Solid NeoplasmRecurrent Childhood EpendymomaRecurrent Ewing Sarcoma+29 more
National Cancer Institute (NCI) 23
Testing effectiveness (Phase 2)Active Not RecruitingNCT03210714
What this trial is testing

Erdafitinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With FGFR Mutations (A Pediatric MATCH Treatment Trial)

Who this might be right for
Advanced Malignant Solid NeoplasmRecurrent Childhood EpendymomaRecurrent Childhood Malignant Germ Cell Tumor+29 more
National Cancer Institute (NCI) 20
Early research (Phase 1)Study completedNCT01240538
What this trial is testing

Viral Therapy in Treating Young Patients With Relapsed or Refractory Solid Tumors

Who this might be right for
Unspecified Childhood Solid Tumor, Protocol Specific
National Cancer Institute (NCI) 26
Testing effectiveness (Phase 2)Active Not RecruitingNCT03899792
What this trial is testing

Oral LOXO-292 (Selpercatinib) in Pediatric Participants With Advanced Solid or Primary Central Nervous System (CNS) Tumors

Who this might be right for
Medullary Thyroid CancerInfantile MyofibromatosisInfantile Fibrosarcoma+2 more
Eli Lilly and Company 36
Early research (Phase 1)WithdrawnNCT02800889
What this trial is testing

Dose-Escalation Study of Pixantrone Monotherapy in Pediatric Patients With Relapsed or Refractory Cancer

Who this might be right for
LymphomaSolid Tumor (Excluding CNS)
CTI BioPharma
Testing effectiveness (Phase 2)Ended earlyNCT02541604
What this trial is testing

Evaluate the Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Preliminary Efficacy of Atezolizumab (Anti-Programmed Death-Ligand 1 [PD-L1] Antibody) in Pediatric and Young Adult Participants With Solid Tumors

Who this might be right for
Solid Tumor
Hoffmann-La Roche 87
Early research (Phase 1)Study completedNCT02808650
What this trial is testing

Prexasertib in Treating Pediatric Patients With Recurrent or Refractory Solid Tumors

Who this might be right for
Childhood Solid NeoplasmRecurrent Malignant Solid NeoplasmRecurrent Primary Central Nervous System Neoplasm+2 more
Children's Oncology Group 30
Large-scale testing (Phase 3)Looking for participantsNCT06208917
What this trial is testing

Ondansetron (ODF) Versus Ondansetron Intravenously for the Prevention of Chemotherapy-induced Nausea and Vomiting Compare in Children

Who this might be right for
Pediatric Solid Tumor, Unspecified, Protocol Specific
Yizhuo Zhang 376
Early research (Phase 1)Study completedNCT00186979
What this trial is testing

Study of ZD1839 Combined With Irinotecan and Vincristine in Pediatric Patients With Refractory Solid Tumors

Who this might be right for
Solid Tumors
St. Jude Children's Research Hospital 34
Testing effectiveness (Phase 2)Ended earlyNCT00069927
What this trial is testing

Adderall XR Compared With Concerta in Treating Young Cancer Patients With Memory, Attention, and Depression

Who this might be right for
DepressionNeurotoxicityUnspecified Childhood Solid Tumor, Protocol Specific
University of South Florida 12
Testing effectiveness (Phase 2)Active Not RecruitingNCT03834961
What this trial is testing

Larotrectinib in Treating Patients With Previously Untreated TRK Fusion Solid Tumors and TRK Fusion Relapsed Acute Leukemia

Who this might be right for
Central Nervous System NeoplasmInfantile FibrosarcomaRecurrent Acute Leukemia+2 more
Children's Oncology Group 33
Testing effectiveness (Phase 2)Study completedNCT02499861
What this trial is testing

Phase I/II a Study of Decitabine in Combination With Genistein in Pediatric Relapsed or Refractory Malignancies

Who this might be right for
Cancer
St. Justine's Hospital 6
Early research (Phase 1)Study completedNCT02677116
What this trial is testing

Olaratumab Alone and in Combination With Standard Chemotherapies in Children With Cancer

Who this might be right for
Neoplasm Metastasis
Eli Lilly and Company 68
Next Page